BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1110 related articles for article (PubMed ID: 22505239)

  • 1. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.
    Nebbia G; Peppa D; Schurich A; Khanna P; Singh HD; Cheng Y; Rosenberg W; Dusheiko G; Gilson R; ChinAleong J; Kennedy P; Maini MK
    PLoS One; 2012; 7(10):e47648. PubMed ID: 23112829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
    Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
    J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
    Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
    Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
    Komita H; Koido S; Hayashi K; Kan S; Ito M; Kamata Y; Suzuki M; Homma S
    Oncol Rep; 2015 Oct; 34(4):2099-105. PubMed ID: 26239720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].
    Ji P; Chen D; Bian J; Xia R; Song X; Wen W; Zhang X; Zhu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):808-11. PubMed ID: 26062425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.
    Chen Z; Dong D; Zhu Y; Pang N; Ding J
    FASEB J; 2021 Mar; 35(3):e21401. PubMed ID: 33559190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular Carcinoma.
    Xue H; Lin F; Tan H; Zhu ZQ; Zhang ZY; Zhao L
    PLoS One; 2016; 11(5):e0154815. PubMed ID: 27136203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma.
    Jiao J; Jiao D; Yang F; Zhang J; Li Y; Han D; Zhang K; Wang Y; Zhang R; Yang AG; Wang A; Wen W; Qin W
    Aging (Albany NY); 2022 Feb; 14(4):1879-1890. PubMed ID: 35202002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.
    Duan Z; Gao J; Zhang L; Liang H; Huang X; Xu Q; Zhang Y; Shen T; Lu F
    Oncotarget; 2015 Dec; 6(42):44239-53. PubMed ID: 26517519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.
    Mujib S; Jones RB; Lo C; Aidarus N; Clayton K; Sakhdari A; Benko E; Kovacs C; Ostrowski MA
    J Immunol; 2012 Apr; 188(8):3745-56. PubMed ID: 22422881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) polymorphisms with susceptibility and disease progression of HBV infection.
    Liao J; Zhang Q; Liao Y; Cai B; Chen J; Li L; Wang L
    PLoS One; 2014; 9(5):e98280. PubMed ID: 24867713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size.
    Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Mandeli J; Hiotis SP
    J Immunother; 2016 Jan; 39(1):36-44. PubMed ID: 26641260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection.
    Mengshol JA; Golden-Mason L; Arikawa T; Smith M; Niki T; McWilliams R; Randall JA; McMahan R; Zimmerman MA; Rangachari M; Dobrinskikh E; Busson P; Polyak SJ; Hirashima M; Rosen HR
    PLoS One; 2010 Mar; 5(3):e9504. PubMed ID: 20209097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1
    Ye L; Zhang Q; Cheng Y; Chen X; Wang G; Shi M; Zhang T; Cao Y; Pan H; Zhang L; Wang G; Deng Y; Yang Y; Chen G
    J Immunother Cancer; 2018 Dec; 6(1):145. PubMed ID: 30526680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
    Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.